Posterior Reversible Encephalopathy Syndrome (PRES) and the Life-Saving Intensive Care Unit

Year 2017, Volume: 22 Issue: 1, 46 - 49, 30.12.2016

Muhittin Çalım Hayrettin Daşkaya Ferda İnal Kadir İdin İbrahim Ölçülü Ziya Salihoğlu

https://doi.org/10.21673/anadoluklin.252168

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a term defining a condition characterized with a set of clinical and radiological symptoms including epileptic attacks, abnormal changes in consciousness, headache, visual abnormalities, nausea and vomiting. It is diagnosed through MRI by observing bilateral and symmetric cerebral edema in occipital and parietal lobes. In this case report, we present the treatment and follow-up process in the intensive care unit of a patient who developed PRES with underlying preeclampsia.

Keywords

Posterior Reversible Encephalopathy Syndrome (PRES), Preeclampsia, Cerebral Vasogenic Edema

Posteriyor Reversibl Ensefalopati Sendromu (PRES) ve Hayat Kurtarıcı Yoğun Bakım Ünitesi

Abstract

Posteriyor reversibl ensefalopati sendromu (PRES); epileptik nöbetler, bilinç durum bozuklukları,
baş ağrısı, görme anormallikleri ve bulantı/kusma gibi birtakım klinik–radyolojik semptomların
söz konusu olduğu tablo için kullanılan bir tanımlamadır. Tanı MRG’de parietal ve oksipital bölgede
daha belirgin olan bilateral ve simetrik serebral ödem gözlemi ile konur. Bu yazıda, preeklampsi
zemininde PRES gelişen bir hastanın yoğun bakım ünitesindeki takip ve tedavisi, güncel
literatür eşliğinde sunulmuştur.

Keywords

Posterior Reversible Ensefalopati Sendromu (PRES), Preeklampsi, Serebral Vazojenik Ödem

References

• 1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500.
• 2. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008;65:205–10.
• 3. J.-L. Vincent (ed.), Annual Update in Intensive Care and Emergency Medicine 2011. DOI 10.1007/978-3-642-18081-1, Springer Science Business Media LLC 2011.
• 4. Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg 2010;112:886–89.
• 5. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008;29:036-42.
• 6. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2007;28:1320–27.
• 7. O'Hara McCoy H. Posterior reversible encephalopathy syndrome: an emerging clinical entity in adult, pediatric, and obstetric critical care. J Am Acad Nurse Pract 2008;20:100-6.
• 8. Chou MC, Lai PH, Yeh LR, Li JY, Yuan MK, Liang HL, et al. Posterior reversible encephalopathy syndrome: magnetic resonance imaging and diffusion-weighted imaging in 12 cases. Kaohsiung J Med Sci 2004;20:381-8.